These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 8069589

  • 21. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV.
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [Abstract] [Full Text] [Related]

  • 22. Enhanced tumor uptake of macromolecules induced by a novel vasoactive interleukin 2 immunoconjugate.
    LeBerthon B, Khawli LA, Alauddin M, Miller GK, Charak BS, Mazumder A, Epstein AL.
    Cancer Res; 1991 May 15; 51(10):2694-8. PubMed ID: 2021947
    [Abstract] [Full Text] [Related]

  • 23. Evidence that an anthracycline-anti-CD8 immunoconjugate, idarubicin-anti-Ly-2.1, prolongs heart allograft survival in mice.
    Mottram PL, Pietersz GA, Smyth MJ, Purcell LJ, Clunie GJ, McKenzie IF.
    Transplantation; 1993 Mar 15; 55(3):484-90. PubMed ID: 8456465
    [Abstract] [Full Text] [Related]

  • 24. chFRP5-ZZ-PE38, a large IgG-toxin immunoconjugate outperforms the corresponding smaller FRP5(Fv)-ETA immunotoxin in eradicating ErbB2-expressing tumor xenografts.
    Mazor Y, Noy R, Wels WS, Benhar I.
    Cancer Lett; 2007 Nov 08; 257(1):124-35. PubMed ID: 17698286
    [Abstract] [Full Text] [Related]

  • 25. Improved antitumor effects of immunotoxins prepared with deglycosylated ricin A-chain and hindered disulfide linkages.
    Thorpe PE, Wallace PM, Knowles PP, Relf MG, Brown AN, Watson GJ, Blakey DC, Newell DR.
    Cancer Res; 1988 Nov 15; 48(22):6396-403. PubMed ID: 3263186
    [Abstract] [Full Text] [Related]

  • 26. [Experimental study of anti-tumor effect with conjugates of monoclonal antibodies and hematoporphyrin derivative].
    Xu SX, Wang NQ, Dong ZW.
    Yao Xue Xue Bao; 1989 Nov 15; 24(6):401-6. PubMed ID: 2532854
    [Abstract] [Full Text] [Related]

  • 27. An antibody-cytotoxic conjugate, BIIB015, is a new targeted therapy for Cripto positive tumours.
    Kelly RK, Olson DL, Sun Y, Wen D, Wortham KA, Antognetti G, Cheung AE, Orozco OE, Yang L, Bailly V, Sanicola M.
    Eur J Cancer; 2011 Jul 15; 47(11):1736-46. PubMed ID: 21458984
    [Abstract] [Full Text] [Related]

  • 28. Synergistic potentiation of in vivo antitumor activity of anti-human T-leukemia immunotoxins by recombinant alpha-interferon and daunorubicin.
    Yokota S, Hara H, Luo Y, Seon BK.
    Cancer Res; 1990 Jan 01; 50(1):32-7. PubMed ID: 2293557
    [Abstract] [Full Text] [Related]

  • 29. [The antitumor effect of adriamycin conjugated with monoclonal antibody against gastric cancer in vitro and in vivo].
    Zhang YT, Wang NQ, Li N, Liu T, Dong ZW.
    Yao Xue Xue Bao; 1992 Jan 01; 27(5):325-30. PubMed ID: 1442051
    [Abstract] [Full Text] [Related]

  • 30. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
    Furrer M, Altermatt HJ, Ris HB, Althaus U, Rüegg C, Liénard D, Lejeune FJ.
    Melanoma Res; 1997 Aug 01; 7 Suppl 2():S43-9. PubMed ID: 9578416
    [Abstract] [Full Text] [Related]

  • 31. The in vitro and in vivo anti-tumour activity of N-AcMEL-(Fab')2 conjugates.
    Smyth MJ, Pietersz GA, McKenzie IF.
    Br J Cancer; 1987 Jan 01; 55(1):7-11. PubMed ID: 3814478
    [Abstract] [Full Text] [Related]

  • 32. Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models.
    Shah SA, Halloran PM, Ferris CA, Levine BA, Bourret LA, Goldmacher VS, Blättler WA.
    Cancer Res; 1993 Mar 15; 53(6):1360-7. PubMed ID: 7680284
    [Abstract] [Full Text] [Related]

  • 33. Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate.
    Hamblett KJ, Senter PD, Chace DF, Sun MM, Lenox J, Cerveny CG, Kissler KM, Bernhardt SX, Kopcha AK, Zabinski RF, Meyer DL, Francisco JA.
    Clin Cancer Res; 2004 Oct 15; 10(20):7063-70. PubMed ID: 15501986
    [Abstract] [Full Text] [Related]

  • 34. The combination regimen of idarubicin and taxotere is effective against human drug-resistant leukemic cell lines.
    Majlessipour F, Avramis IA, Kwock R, Weinberg KI, Avrami VI.
    Anticancer Res; 2002 Oct 15; 22(3):1361-8. PubMed ID: 12168812
    [Abstract] [Full Text] [Related]

  • 35. Superiority of an acid-labile daunorubicin-monoclonal antibody immunoconjugate compared to free drug.
    Dillman RO, Johnson DE, Shawler DL, Koziol JA.
    Cancer Res; 1988 Nov 01; 48(21):6097-102. PubMed ID: 3262420
    [Abstract] [Full Text] [Related]

  • 36. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
    Safavy A, Bonner JA, Waksal HW, Buchsbaum DJ, Gillespie GY, Khazaeli MB, Arani R, Chen DT, Carpenter M, Raisch KP.
    Bioconjug Chem; 2003 Nov 01; 14(2):302-10. PubMed ID: 12643740
    [Abstract] [Full Text] [Related]

  • 37. In vivo antitumor effects of monoclonal antibodies with different immunoglobulin classes.
    Seto M, Takahashi T, Nakamura S, Matsudaira Y, Nishizuka Y.
    Cancer Res; 1983 Oct 01; 43(10):4768-73. PubMed ID: 6192909
    [Abstract] [Full Text] [Related]

  • 38. Therapeutic effects of monoclonal antibody-beta-lactamase conjugates in combination with a nitrogen mustard anticancer prodrug in models of human renal cell carcinoma.
    Svensson HP, Frank IS, Berry KK, Senter PD.
    J Med Chem; 1998 Apr 23; 41(9):1507-12. PubMed ID: 9554883
    [Abstract] [Full Text] [Related]

  • 39. Experimental treatment of malignant gliomas with human monoclonal antibody-drug conjugates.
    Takahashi H, Adachi K, Yamaguchi F, Teramoto A.
    Anticancer Res; 1999 Apr 23; 19(5B):4151-5. PubMed ID: 10628367
    [Abstract] [Full Text] [Related]

  • 40. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
    Thorpe PE, Brown AN, Bremner JA, Foxwell BM, Stirpe F.
    J Natl Cancer Inst; 1985 Jul 23; 75(1):151-9. PubMed ID: 3859688
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.